Global Patent Index - EP 1021134 A1

EP 1021134 A1 20000726 - USE OF HEMOGLOBIN TO PREVENT SEPSIS OR TREAT SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

Title (en)

USE OF HEMOGLOBIN TO PREVENT SEPSIS OR TREAT SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

Title (de)

VERWENDUNG VON HÄMOGLOBIN ZUR VERMEIDUNG VON SEPSIS ODER BEHANDLUNG DES SYSTEMISCH-ENTZÜNDLICHEN REAKTIONS SYNDROMS

Title (fr)

UTILISATION D'HEMOGLOBINE POUR PREVENIR LA SEPTICEMIE OU TRAITER LE SYNDROME DE LA REPONSE INFLAMMATOIRE GENERALISEE

Publication

EP 1021134 A1 20000726 (EN)

Application

EP 97946235 A 19971112

Priority

  • US 9715854 W 19971112
  • US 74549596 A 19961112

Abstract (en)

[origin: WO9820803A1] Methods for reducing the severity of or preventing sepsis in a patient at risk for developing sepsis or treating systemic inflammatory response syndrome in a patient diagnosed as suffering from systemic inflammatory response syndrome by administering a hemoglobin preparation to the patient.

IPC 1-7

A61B 19/00; A61K 38/42

IPC 8 full level

A61B 19/00 (2006.01); A61D 7/00 (2006.01); A61K 38/16 (2006.01); A61K 38/42 (2006.01); A61P 7/00 (2006.01)

CPC (source: EP)

A61K 38/42 (2013.01); A61P 7/00 (2017.12)

Designated contracting state (EPC)

DE FR GB

DOCDB simple family (publication)

WO 9820803 A1 19980522; AU 5144998 A 19980603; AU 722301 B2 20000727; CA 2270772 A1 19980522; EP 1021134 A1 20000726; EP 1021134 A4 20040609; JP 2001505875 A 20010508; ZA 979540 B 19980512

DOCDB simple family (application)

US 9715854 W 19971112; AU 5144998 A 19971112; CA 2270772 A 19971112; EP 97946235 A 19971112; JP 52253798 A 19971112; ZA 979540 A 19971024